• Je něco špatně v tomto záznamu ?

Amelioration of Endotoxin-Induced Acute Lung Injury and Alveolar Epithelial Cells Apoptosis by Simvastatin Is Associated with Up-Regulation of Survivin/NF-kB/p65 Pathway

L. Nežić, L. Amidžić, R. Škrbić, R. Gajanin, D. Mandić, J. Dumanović, Z. Milovanović, V. Jaćević

. 2022 ; 23 (5) : . [pub] 20220226

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22019354

Disruption of the alveolar-endothelial barrier caused by inflammation leads to the progression of septic acute lung injury (ALI). In the present study, we investigated the beneficial effects of simvastatin on the endotoxin lipopolysaccharide (LPS)-induced ALI and its related mechanisms. A model of ALI was induced within experimental sepsis developed by intraperitoneal injection of a single non-lethal LPS dose after short-term simvastatin pretreatment (10-40 mg/kg orally). The severity of the lung tissue inflammatory injury was expressed as pulmonary damage scores (PDS). Alveolar epithelial cell apoptosis was confirmed by TUNEL assay (DNA fragmentation) and expressed as an apoptotic index (AI), and immunohistochemically for cleaved caspase-3, cytochrome C, and anti-apoptotic Bcl-xL, an inhibitor of apoptosis, survivin, and transcriptional factor, NF-kB/p65. Severe inflammatory injury of pulmonary parenchyma (PDS 3.33 ± 0.48) was developed after the LPS challenge, whereas simvastatin significantly and dose-dependently protected lung histology after LPS (p < 0.01). Simvastatin in a dose of 40 mg/kg showed the most significant effects in amelioration alveolar epithelial cells apoptosis, demonstrating this as a marked decrease of AI (p < 0.01 vs. LPS), cytochrome C, and cleaved caspase-3 expression. Furthermore, simvastatin significantly enhanced the expression of Bcl-xL and survivin. Finally, the expression of survivin and its regulator NF-kB/p65 in the alveolar epithelium was in strong positive correlation across the groups. Simvastatin could play a protective role against LPS-induced ALI and apoptosis of the alveolar-endothelial barrier. Taken together, these effects were seemingly mediated by inhibition of caspase 3 and cytochrome C, a finding that might be associated with the up-regulation of cell-survival survivin/NF-kB/p65 pathway and Bcl-xL.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019354
003      
CZ-PrNML
005      
20220804135602.0
007      
ta
008      
220720s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms23052596 $2 doi
035    __
$a (PubMed)35269738
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Nežić, Lana $u Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Banja Luka, 14 Save Mrkalja St., 78000 Banja Luka, Bosnia and Herzegovina $1 https://orcid.org/0000000242175437
245    10
$a Amelioration of Endotoxin-Induced Acute Lung Injury and Alveolar Epithelial Cells Apoptosis by Simvastatin Is Associated with Up-Regulation of Survivin/NF-kB/p65 Pathway / $c L. Nežić, L. Amidžić, R. Škrbić, R. Gajanin, D. Mandić, J. Dumanović, Z. Milovanović, V. Jaćević
520    9_
$a Disruption of the alveolar-endothelial barrier caused by inflammation leads to the progression of septic acute lung injury (ALI). In the present study, we investigated the beneficial effects of simvastatin on the endotoxin lipopolysaccharide (LPS)-induced ALI and its related mechanisms. A model of ALI was induced within experimental sepsis developed by intraperitoneal injection of a single non-lethal LPS dose after short-term simvastatin pretreatment (10-40 mg/kg orally). The severity of the lung tissue inflammatory injury was expressed as pulmonary damage scores (PDS). Alveolar epithelial cell apoptosis was confirmed by TUNEL assay (DNA fragmentation) and expressed as an apoptotic index (AI), and immunohistochemically for cleaved caspase-3, cytochrome C, and anti-apoptotic Bcl-xL, an inhibitor of apoptosis, survivin, and transcriptional factor, NF-kB/p65. Severe inflammatory injury of pulmonary parenchyma (PDS 3.33 ± 0.48) was developed after the LPS challenge, whereas simvastatin significantly and dose-dependently protected lung histology after LPS (p &lt; 0.01). Simvastatin in a dose of 40 mg/kg showed the most significant effects in amelioration alveolar epithelial cells apoptosis, demonstrating this as a marked decrease of AI (p &lt; 0.01 vs. LPS), cytochrome C, and cleaved caspase-3 expression. Furthermore, simvastatin significantly enhanced the expression of Bcl-xL and survivin. Finally, the expression of survivin and its regulator NF-kB/p65 in the alveolar epithelium was in strong positive correlation across the groups. Simvastatin could play a protective role against LPS-induced ALI and apoptosis of the alveolar-endothelial barrier. Taken together, these effects were seemingly mediated by inhibition of caspase 3 and cytochrome C, a finding that might be associated with the up-regulation of cell-survival survivin/NF-kB/p65 pathway and Bcl-xL.
650    12
$a akutní poškození plic $x chemicky indukované $x farmakoterapie $x metabolismus $7 D055371
650    _2
$a pneumocyty $x metabolismus $7 D056809
650    _2
$a apoptóza $7 D017209
650    _2
$a kaspasa 3 $x genetika $x metabolismus $7 D053148
650    _2
$a cytochromy c $x metabolismus $7 D045304
650    _2
$a endotoxiny $x škodlivé účinky $7 D004731
650    _2
$a lidé $7 D006801
650    _2
$a lipopolysacharidy $x toxicita $7 D008070
650    _2
$a plíce $x patologie $7 D008168
650    12
$a NF-kappa B $x metabolismus $7 D016328
650    _2
$a simvastatin $x škodlivé účinky $7 D019821
650    _2
$a survivin $x genetika $7 D000077022
650    _2
$a upregulace $7 D015854
655    _2
$a časopisecké články $7 D016428
700    1_
$a Amidžić, Ljiljana $u Center for Biomedical Research, Faculty of Medicine, University of Banja Luka, 14 Save Mrkalja St., 78000 Banja Luka, Bosnia and Herzegovina $u Institute of Pathology, University Clinical Center of Republic of Srpska, Faculty of Medicine, University of Banja Luka, 12 Beba St., 78000 Banja Luka, Bosnia and Herzegovina
700    1_
$a Škrbić, Ranko $u Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Banja Luka, 14 Save Mrkalja St., 78000 Banja Luka, Bosnia and Herzegovina $u Center for Biomedical Research, Faculty of Medicine, University of Banja Luka, 14 Save Mrkalja St., 78000 Banja Luka, Bosnia and Herzegovina
700    1_
$a Gajanin, Radoslav $u Institute of Pathology, University Clinical Center of Republic of Srpska, Faculty of Medicine, University of Banja Luka, 12 Beba St., 78000 Banja Luka, Bosnia and Herzegovina
700    1_
$a Mandić, Danijela $u Department of Internal Medicine, School of Medicine, University of Banja Luka, 14 Save Mrkalja St., 78000 Banja Luka, Bosnia and Herzegovina
700    1_
$a Dumanović, Jelena $u Faculty of Chemistry, University of Belgrade, 16 Studenski trg St., 11000 Belgrade, Serbia $u Medical Faculty of the Military Medical Academy, University of Defence in Belgrade, 17 Crnotravska St., 11000 Belgrade, Serbia
700    1_
$a Milovanović, Zoran $u Special Police Unit, Police Department of the City of Belgrade, Ministry of Interior, 12/A Trebevićka St., 11030 Belgrade, Serbia
700    1_
$a Jaćević, Vesna $u Medical Faculty of the Military Medical Academy, University of Defence in Belgrade, 17 Crnotravska St., 11000 Belgrade, Serbia $u Department for Experimental Toxicology and Pharmacology, National Poison Control Centre, Military Medical Academy, 11 Crnotravska St., 11000 Belgrade, Serbia $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, 62 Rokitanského St., 500 03 Hradec Králové, Czech Republic $1 https://orcid.org/0000000151372638
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 23, č. 5 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35269738 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135556 $b ABA008
999    __
$a ok $b bmc $g 1822799 $s 1170597
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 23 $c 5 $e 20220226 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Možnosti archivace